These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 29898629

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Effect of preeclampsia, magnesium sulfate prophylaxis, and maternal weight on labor induction: a retrospective analysis.
    Park KH, Cho YK, Lee CM, Choi H, Kim BR, Lee HK.
    Gynecol Obstet Invest; 2006; 61(1):40-4. PubMed ID: 16179789
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. A comparison between the two methods of magnesium sulfate administration for duration of 12 versus 24 h after delivery in patients with severe preeclampsia.
    Kashanian M, Koohpayehzadeh J, Sheikhansari N, Bararpour F, Sahraian G, Asadolla S.
    J Matern Fetal Neonatal Med; 2016; 29(14):2282-7. PubMed ID: 26364667
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Abbreviated postpartum magnesium sulfate therapy for women with mild preeclampsia: a randomized controlled trial.
    Ehrenberg HM, Mercer BM.
    Obstet Gynecol; 2006 Oct; 108(4):833-8. PubMed ID: 17012443
    [Abstract] [Full Text] [Related]

  • 31. A randomized controlled trial of loading dose alone versus pritchard regimen of magnesium sulphate, for seizure prophylaxis in severe preeclampsia.
    Obanimoh AA, Isah AY, Abdullahi HI, Adewole ND, Ekele BA.
    Ann Afr Med; 2023 Oct; 22(2):153-159. PubMed ID: 37026195
    [Abstract] [Full Text] [Related]

  • 32. A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia.
    Belfort MA, Anthony J, Saade GR, Allen JC, Nimodipine Study Group.
    N Engl J Med; 2003 Jan 23; 348(4):304-11. PubMed ID: 12540643
    [Abstract] [Full Text] [Related]

  • 33. Clinical pharmacokinetic properties of magnesium sulphate in women with pre-eclampsia and eclampsia.
    Okusanya BO, Oladapo OT, Long Q, Lumbiganon P, Carroli G, Qureshi Z, Duley L, Souza JP, Gülmezoglu AM.
    BJOG; 2016 Feb 23; 123(3):356-66. PubMed ID: 26599617
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Alternative Magnesium Sulfate Dosing Regimens for Women With Preeclampsia: A Population Pharmacokinetic Exposure-Response Modeling and Simulation Study.
    Du L, Wenning LA, Carvalho B, Duley L, Brookfield KF, Witjes H, de Greef R, Lumbiganon P, Titapant V, Kongwattanakul K, Long Q, Sangkomkamhang US, Gülmezoglu AM, Oladapo OT.
    J Clin Pharmacol; 2019 Nov 23; 59(11):1519-1526. PubMed ID: 31157410
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Intravenous and intramuscular magnesium sulphate regimens in severe pre-eclampsia.
    Chissell S, Botha JH, Moodley J, McFadyen L.
    S Afr Med J; 1994 Sep 23; 84(9):607-10. PubMed ID: 7839282
    [Abstract] [Full Text] [Related]

  • 39. Neonatal effects of magnesium sulfate given to the mother.
    Abbassi-Ghanavati M, Alexander JM, McIntire DD, Savani RC, Leveno KJ.
    Am J Perinatol; 2012 Nov 23; 29(10):795-9. PubMed ID: 22773290
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.